Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier report that takeover talks had stalled.
The decision is aimed at boosting cash flow and reducing debt as it faces an opioid lawsuit from the Department of Justice.
The change is aimed at improving Walgreens’ finances by reducing debt over time and improving cash flow, the company said.